|
KMID : 0043320160390020202
|
|
Archives of Pharmacal Research
2016 Volume.39 No. 2 p.202 ~ p.212
|
|
|
Formulation of nimodipine nanocrystals for oral administration
|
|
Li Jianwen
Fu Qiang
Liu Xiaohong
Li Mo
Wang Yongjun
|
|
|
Abstract
|
|
|
|
The aim of this paper is to optimize nimodipine (NMD) nanocrystals (NCs) for oral administration. The effects of independent process variables (microprecipitation temperature, shearing speed, shearing time, homogenization pressure and number of cycles) on the particle size have been studied. Experiments were conducted to optimize the formulation composition. A single factor exploration was used to screen the primary stabilizers. Then, the selected polymers/surfactants were further optimized using an L9 (34) orthogonal design. The optimal formulation was composed of NMD (0.7 %, w/v), F127 (0.4 %, w/v), HPMC-E5 (0.1 %, w/v), and sodium deoxycholate (0.05 %, w/v) and was rod-shaped as shown by SEM observations, and it had a particle size of 833.3 ± 20.6 nm, determined by laser diffraction. These aqueous NCs were physically stable for 15 days. To further improve the stability, the NCs were freeze-dried. The powder obtained exhibited acceptable flowability and was physically stable for at least 24 months. Additionally, the NMD NCs displayed much higher dissolution profiles than the bulk drug. The pharmacokinetic results showed that the relative bioavailability was 397 % in comparison with Nimotop®, suggesting that NCs are an efficient strategy for improving the oral bioavailability of poorly water-soluble drugs.
|
|
|
KEYWORD
|
|
|
Nimodipine, Nanocrystals, Preparation, Formulation, Physical stability
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|